Literature DB >> 11162591

cGMP-dependent protein kinase phosphorylates and inactivates RhoA.

N Sawada1, H Itoh, J Yamashita, K Doi, M Inoue, K Masatsugu, Y Fukunaga, S Sakaguchi, M Sone, K Yamahara , T Yurugi, K Nakao.   

Abstract

Small GTPase Rho and cGMP/cGMP-dependent protein kinase (cGK) pathways exert opposing effects in specific systems such as vascular contraction and growth. However, the direct interaction between these pathways has remained elusive. We demonstrate that cGK phosphorylates RhoA in vitro at Ser188, the same residue phosphorylated by cAMP-dependent protein kinase. In HeLa cells transfected with constitutively active cGK (C-cGK), stress fiber formation induced by lysophosphatidic acid or V14RhoA was blocked. By contrast, C-cGK failed to inhibit stress fiber formation in cells transfected with mutant RhoA with substitution of Ser188 to Ala. C-cGK did not affect actin reorganization induced by Rac1 or Rho-associated kinase, one of the effectors for RhoA. Furthermore, C-cGK expression inhibited the membrane translocation of RhoA. Collectively, our findings suggest that cGK phosphorylates RhoA at Ser188 and inactivates RhoA signaling. The physiological relevance of the direct interaction between RhoA and cGK awaits further investigation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162591     DOI: 10.1006/bbrc.2000.4194

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  63 in total

Review 1.  cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.

Authors:  Sharron H Francis; Jennifer L Busch; Jackie D Corbin; David Sibley
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 2.  Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension.

Authors:  M Oka; K A Fagan; P L Jones; I F McMurtry
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

Review 3.  Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.

Authors:  Naoki Sawada; James K Liao
Journal:  Antioxid Redox Signal       Date:  2013-09-24       Impact factor: 8.401

4.  Regulation of RhoA signaling by the cAMP-dependent phosphorylation of RhoGDIα.

Authors:  Atsuro Oishi; Noriko Makita; Junichiro Sato; Taroh Iiri
Journal:  J Biol Chem       Date:  2012-09-25       Impact factor: 5.157

5.  Inhibition of RhoA/Rho kinase pathway is involved in the beneficial effect of sildenafil on pulmonary hypertension.

Authors:  Christophe Guilluy; Vincent Sauzeau; Malvyne Rolli-Derkinderen; Patrice Guérin; Christine Sagan; Pierre Pacaud; Gervaise Loirand
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 6.  Phosphorylation-mediated regulation of GEFs for RhoA.

Authors:  Maulik Patel; Andrei V Karginov
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

7.  The tumor suppressor p53 transcriptionally regulates cGKI expression during neuronal maturation and is required for cGMP-dependent growth cone collapse.

Authors:  Andrea Tedeschi; Tuan Nguyen; Sonya Ulrike Steele; Susanne Feil; Ulrike Naumann; Robert Feil; Simone Di Giovanni
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

Review 8.  Smooth muscle signalling pathways in health and disease.

Authors:  H R Kim; S Appel; S Vetterkind; S S Gangopadhyay; K G Morgan
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

9.  Activation of the nitric oxide-cGMP pathway reduces phasic contractions in neonatal rat bladder strips via protein kinase G.

Authors:  Debra E Artim; F Aura Kullmann; Stephanie L Daugherty; Hsi-Yang Wu; William C de Groat
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-03

10.  Differential regulation of RhoA-mediated signaling by the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor: independent modulation of TPalpha signaling by prostacyclin and nitric oxide.

Authors:  Katarina Wikström; David J Kavanagh; Helen M Reid; B Therese Kinsella
Journal:  Cell Signal       Date:  2008-05-23       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.